CymitQuimica logo

CAS 334758-18-8

:

6-Raloxifene-β-D-glucopyranoside

Description:
6-Raloxifene-β-D-glucopyranoside is a glycosylated derivative of raloxifene, a selective estrogen receptor modulator (SERM) primarily used in the treatment of osteoporosis and breast cancer. This compound features a β-D-glucopyranoside moiety, which enhances its solubility and bioavailability compared to its parent compound. The presence of the glucopyranoside group may also influence its pharmacokinetic properties, potentially affecting absorption, distribution, metabolism, and excretion. As a SERM, 6-Raloxifene-β-D-glucopyranoside exhibits tissue-selective estrogenic activity, which can provide beneficial effects on bone density while minimizing estrogen-related side effects in other tissues. Its chemical structure includes multiple functional groups that contribute to its biological activity and interaction with estrogen receptors. Research into this compound may focus on its efficacy, safety profile, and potential therapeutic applications, particularly in conditions influenced by estrogen signaling. Overall, 6-Raloxifene-β-D-glucopyranoside represents a significant area of interest in medicinal chemistry and pharmacology.
Formula:C34H37NO9S
Synonyms:
  • 6-Raloxifene-β-D-glucopyranoside
  • Methanone, [6-(β-D-glucopyranosyloxy)-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.